Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Jd Com Adr Representing 2 Class A
JD
JD.Com Inc is a company principally engaged in the e-commerce business, including online retail and online marketplace mainly through its retail mobile apps and www.jd.com website (collectively, JD Platform). The Company operates its businesses through four segments. JD Retail segment, including JD Health, JD Industrials, and other components, mainly engage in online retail, online marketplace...
and marketing services in China. JD Logistics segment includes both internal and external logistics businesses. Dada segment is a local on-demand delivery and retail platform in China. New Businesses segment mainly include JD Property, Jingxi and overseas businesses. The Company mainly conducts its businesses in the domestic market and overseas markets.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:JD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(5)
•••
10QKing
X
Post by
10QKing
on Nov 08, 2024 10:30am
Trump bans Americans from investing in Chinese firms he clai
Trump bans Americans from investing in Chinese firms he claims have ties to the military https://www.cnn.com/2020/11/12/investing/trump-bans-us-investments-china-military/index.html US Investors maybe
...more
(276)
•••
whytestocks
X
Post by
whytestocks
on Sep 27, 2024 4:15pm
(JD) Investment Analysis and Advice
News; $JD (JD) Investment Analysis and Advice2024-09-27 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the
...more
(276)
•••
whytestocks
X
Post by
whytestocks
on Jun 21, 2024 10:45pm
Market Perform Recommendation Issued On JD By Morgan Stanley
NEWS: $JD Market Perform Recommendation Issued On JD By Morgan Stanley2024-06-21 12:30:05 ET Morgan Stanley analyst issues MARKET PERFORM recommendation for JD on June 21, 2024 10:01AM ET. The
...more
(276)
•••
whytestocks
X
Post by
whytestocks
on May 21, 2024 8:30pm
JD.com Publishes Its Unaudited Interim Condensed Consolidate
News; $JD JD.com Publishes Its Unaudited Interim Condensed Consolidated Financial StatementsBEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD” or the “
...more
(276)
•••
whytestocks
X
Post by
whytestocks
on Feb 14, 2024 4:30am
Emerging Markets Guru Says 'Time To Go Shopping For Hidden G
NEWS: $JD Emerging Markets Guru Says 'Time To Go Shopping For Hidden Gems At A Steal' As He Sees Opportunities In Bruised Chinese, Hong Kong Stocks | BenzingaEmerging markets fund manager Mark
...more
(276)
•••
whytestocks
X
Post by
whytestocks
on Feb 04, 2024 8:30am
Could This Low-Performing Stock Make You a Millionaire?
NEWS: $JD Could This Low-Performing Stock Make You a Millionaire?2024-02-04 08:03:00 ET JD.com (NASDAQ: JD) continues to grapple with its share of geopolitical and economic challenges as a prominent
...more
(0)
•••
Denver67
X
Post by
Denver67
on Apr 13, 2023 3:46am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
Denver67
X
Post by
Denver67
on Jul 15, 2022 9:22pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
Denver67
X
Post by
Denver67
on Jun 03, 2022 5:06am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of
...more
(0)
•••
Denver67
X
Post by
Denver67
on Jun 02, 2022 12:18am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
Denver67
X
Post by
Denver67
on May 11, 2022 1:27am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
Denver67
X
Post by
Denver67
on May 01, 2022 11:38pm
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
Denver67
X
Post by
Denver67
on Apr 24, 2022 1:43am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
Denver67
X
Post by
Denver67
on Apr 18, 2022 2:20am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
Denver67
X
Post by
Denver67
on Apr 09, 2022 2:51am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec